ondasdechoque.org
PT-BR

What early diabetic-foot reports suggested · Review · 2015

What did early studies find about shockwave for diabetic foot ulcers?

This 2015 review gathered early studies of shockwave for diabetic foot ulcers. In the controlled trials it describes, more ulcers healed, and healed faster, with shockwave than with the comparison treatments. The best dose, and whether repeat booster sessions help, are still open questions.

Possible early help for diabetic foot ulcers
narrative review of early studies
2015
years: the longest follow-up it describes
5
comparison treatments: wound care alone or hyperbaric oxygen
2

Good to know: A narrative review: it describes studies one by one rather than combining their results.

Wang CJ, Cheng JH, Kuo YR, et al. Int J Surg, 2015 · Read the paper ↗

How this study worked

One answer
A review gathers earlier studies to answer one question. Illustration, not to scale.

What the trials used

Reported protocol
Protocols varied: Moretti 100 pulses/cm² at 0.03 mJ/mm² every 72 h for three sessions; Saggini 0.037 mJ/mm²; Wang 2009 every second week for 6 weeks; no single validated wound protocol.

Who took part

Earlier studies of people with diabetic and other foot ulcers; no new patients.

Side effects

The review says the studies found no notable side effects.

All the numbers and the full appraisal
FROM THE FULL PAPER

What the full paper reports.

Narrative review of diabetic and mixed foot-ulcer clinical studies; no new patient cohort or pooled analysis.

Clinical healing signals1 reported outcome
01
Study-specific, up to 5 years

Clinical healing signals

Clinical healing signals qualitative evidence

Small controlled studies report higher healing/faster closure; uncontrolled long-term evidence cannot establish durable treatment benefit. No pooled estimate is provided.

Analysis details and source

Small controlled studies report higher healing/faster closure; uncontrolled long-term evidence cannot establish durable treatment benefit. No pooled estimate is provided.

How treatment was delivered
Reported protocol

Protocols varied: Moretti 100 pulses/cm² at 0.03 mJ/mm² every 72 h for three sessions; Saggini 0.037 mJ/mm²; Wang 2009 every second week for 6 weeks; no single validated wound protocol.

HARMS & TOLERABILITY

The review says the cited studies reported no noteworthy side effects (Schaden et al. observed no adverse effect) but gives no harms counts, denominators or systematic surveillance.

LIMITS OF THE ANALYSIS

No reproducible search, selection criteria or formal bias assessment. Strong superiority and cost-effectiveness language exceeds the narrative evidence. It mixes nonrandomized cohorts with randomized trials. Funding and conflicts declared none in this review.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • No reproducible search, selection criteria or formal bias assessment. Strong superiority and cost-effectiveness language exceeds the narrative evidence. It mixes nonrandomized cohorts with randomized trials. Funding and conflicts declared none in this review.
Research review

Source-linked critical reading

Narrative review

Reading depthMaterial consulted
Technical source record

Full 3-page narrative review read: highlights, abstract, Sections 1–5 (introduction, diabetic and non-diabetic ulcers, ESWT versus hyperbaric oxygen, long-term outcomes, conclusion), declarations and references. The review has no methods section, tables or figures; no supplements.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Study design

Narrative clinical review of selected wound studies. It supplies no reproducible search strategy, selection flow, formal bias assessment or pooled estimate, and contributes no new patient cohort.

Participants and setting

Narrative review of diabetic and mixed foot-ulcer clinical studies; no new patient cohort or pooled analysis.

Treatment delivered

Regimens differed between the cited studies: mostly 100 impulses/cm² (Wang 2009: 300 + 100/cm²; the long-term study: treatment area in cm² × 8, at least 500 impulses) at 0.03–0.11 mJ/mm², given from every 72 hours to every second week, or twice a week for six treatments. The review does not say whether the devices were focused.

What was compared

Standard wound care, HBOT, and uncontrolled cohorts; comparisons belong to their original studies.

Outcomes and timing

The cited reports assess complete ulcer closure, time to healing, perfusion, histologic or molecular markers, and late wound outcomes. Their populations, comparators and follow-up windows differ; no common prespecified review outcome or meta-analysis is provided.

Results in context

Moretti is summarized as 53.33% versus 33.33% closure; Omar as 54% versus 28.5% at 20 weeks and 64.5±8.06 versus 81.17±4.35 days among healed ulcers. The 2011 HBOT comparison reports 57% versus 25%. In the long-term study, complete healing was 55.6% at 1 year and 57.4% at 5 years (48% and 43% with diabetes, 66% and 71% without), while perfusion rose for a year and then fell between years 1 and 5.

Harms and tolerability

The review says the cited studies reported no noteworthy side effects (Schaden et al. observed no adverse effect) but gives no harms counts, denominators or systematic surveillance.

Limits and disclosures

No reproducible search, selection criteria or formal bias assessment. Strong superiority and cost-effectiveness language exceeds the narrative evidence. It mixes nonrandomized cohorts with randomized trials. Funding and conflicts declared none in this review.

Clinical applicability

Useful historical overview, not an independent estimate of benefit or evidence for booster sessions.

What a next study should resolve

An updated systematic review should search reproducibly, assess trial bias, separate ulcer etiologies and comparators, and evaluate long-term benefit and booster schedules only from controlled evidence.

THE ORIGINAL SOURCE

Read the original article.

Extracorporeal shockwave therapy in diabetic foot ulcers

Wang CJ, Cheng JH, Kuo YR, Schaden W, Mittermayr R. · Int J Surg · 2015

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →